Home › Funds › Aldebaran Capital, LLC › PMVP
Aldebaran Capital, LLC position in PMVP
PMV PHARMACEUTICALS INC · Health Care
Aldebaran Capital, LLC reported holding 489,540 shares of PMVP (PMV PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$818K, representing 0.59% of its reported portfolio and ranking #30 among its reported holdings. Aldebaran Capital, LLC has disclosed PMVP holdings in 10 of the last 10 reported quarters, going back to Q2 2024.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How Aldebaran Capital, LLC's PMVP position evolved
Aldebaran Capital, LLC first disclosed a stake in PMVP in Q2 2024 at 351,243 shares (US$569K). The position peaked in Q3 2026 at 489,540 shares, worth US$818K. Across 10 filings, Aldebaran Capital, LLC increased the stake 4 time(s), trimmed it 5 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 489,540 shares valued at US$818K — an increase of 22,108 shares quarter over quarter..
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2024 | 351.24K | $569.01K | New |
| Q3 2024 | 438.25K | $653.00K | Add |
| Q4 2024 | 502.19K | $758.31K | Add |
| Q1 2025 | 523.55K | $570.67K | Add |
| Q2 2025 | 515.13K | $546.04K | Reduce |
| Q3 2025 | 504.13K | $705.78K | Reduce |
| Q4 2025 | 477.99K | $597.49K | Reduce |
| Q1 2026 | 473.36K | $586.97K | Reduce |
| Q2 2026 | 467.43K | $626.36K | Reduce |
| Q3 2026 | 489.54K | $817.53K | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About PMVP and 13F data
PMVP (PMV PHARMACEUTICALS INC) is a Health Care company. 21 other funds we track also report a position in PMVP — the largest reported positions include BML Capital Management, LLC (US$12.2M), TANG CAPITAL MANAGEMENT LLC (US$5.7M), Sio Capital Management, LLC (US$3.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding PMVP
- BML Capital Management, LLC 7.33M sh · $12.24M · Q3 2026
- TANG CAPITAL MANAGEMENT LLC 4.25M sh · $5.69M · Q2 2026
- Sio Capital Management, LLC 2.63M sh · $3.53M · Q2 2026
- Euclidean Capital LLC 2.63M sh · $3.52M · Q2 2026
More on Aldebaran Capital, LLC
FAQ
How long has Aldebaran Capital, LLC held PMVP?
Aldebaran Capital, LLC has disclosed PMVP holdings in 10 of the last 10 reported quarters, going back to Q2 2024.
What is Aldebaran Capital, LLC's current position in PMVP?
As of Q3 2026, Aldebaran Capital, LLC holds 489.54K shares of PMVP (PMV PHARMACEUTICALS INC), valued at $817.53K, representing 0.59% of its reported portfolio and ranking #30.
Has Aldebaran Capital, LLC been buying or selling PMVP?
In the latest 13F filing (Q3 2026), Aldebaran Capital, LLC increased its position in PMVP. The position peaked in Q3 2026 at 489.54K shares.
Which other funds hold PMVP?
Other major institutional holders of PMVP include BML Capital Management, LLC, TANG CAPITAL MANAGEMENT LLC, Sio Capital Management, LLC, among 21 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.